Skip to main content

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Agency for Care Effectiveness

Our expert panels

Members of the International Advisory Panel and ACE Consumer Panel.

Last updated 1 December 2025

On this page

International Advisory Panel
ACE Consumer Panel

International Advisory Panel

The International Advisory Panel (IAP) plays a critical advisory role for ACE as we develop, review and implement our various workstreams such as conducting health technology assessments (HTA), publishing healthcare guidances and providing education to support providers, patients and payers make better-informed decisions about patient care. The key aim is to achieve cost-effective and appropriate healthcare in Singapore. The Panel will also offer global perspectives which will help us keep abreast with relevant developments and initiatives internationally. IAP members are appointed for a three-year term starting from 1 Mar 2023 to 28 Feb 2026.

The IAP’s terms of reference are to advise ACE on the following areas:

  1. Critique, recommend improvements and advise on ACE’s methods and processes, workplan and initiatives to keep abreast with international best practices. This can include drug and medical technology evaluation methods and processes, company submission’s methods and process manual, and guidance development methods and processes;

  2. Provide insights on emerging trends and developments in HTA, and/or guidance development and evidence implementation;

  3. Share approaches to guide Singapore’s implementation efforts to build capabilities in HTA, guidance development and execution of evidence-based practice; conduct training for ACE staff; and assist to coordinate training for ACE staff in these areas when required, including recommending trainers to provide training for ACE;

  4. Connect ACE to international networks in the areas of HTA, guidance development and/or evidence implementation; and

  5. Provide mentorship to ACE staff for areas such as HTA, guidance development, evidence implementation, human resource development, strategic communications and use of information technology to develop internal competencies within ACE for further organisational growth, as well as support putting in place best practices for the long-term organisational needs of ACE.

Current IAP Members

Natalie McMurtry (since Sep 2025)

  • Chief Executive, Pharmaceutical Management Agency (Pharmac), New Zealand

Prof Terry Campbell (since Mar 2021)

  • Emeritus Professor of Medicine, University of New South Wales (UNSW Sydney), Australia

  • Chair, Medical Devices and Human Tissue Advisory Committee (MDHTAC)

  • Emeritus Consultant Physician, St Vincent’s Hospital, Sydney.

Prof Mark Jit (since Aug 2019)

  • Professor and Chair of the Department of Global and Environmental Health, New York University, United States

Sudha Kutty (since Mar 2023)

  • Executive Vice-President of Evidence, Products, and Services, Canada's Drug Agency (CDA-AMC), Canada

Prof Nicholas Latimer (since Mar 2021)

  • Professor of Health Economics, School of Health & Related Research, The University of Sheffield, United Kingdom

  • Member, National Institute for Health and Care Excellence (NICE) Decision Support Unit

  • Member, NICE Technology Appraisal Committee B (2018-2022)

  • Member, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Health Science Policy Council (2020-2022)

Prof Tracy Merlin (since Mar 2019)

  • Professor of Health Technology Assessment and Head, School of Public Health, University of Adelaide, Australia

  • Managing Director, Adelaide Health Technology Assessment (AHTA)

  • Past Chair (2023-2025), Board of the International Network of Agencies for Health Technology Assessment (INAHTA)

  • Chair, English Editorial Board, International HTA Glossary

Prof Zachary Munn (since Sep 2023)

  • Director, Health Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, The University of Adelaide, Australia

  • Director, JBI Adelaide GRADE Centre

  • Chair, Guidelines International Network (GIN)

Dr Sam Roberts (since Mar 2023)

  • Chief Executive, National Institute for Health and Care Excellence (NICE), United Kingdom

Prof Debra Rowett (since Apr 2020)

  • Discipline Leader Pharmacy: External Relations, UniSA Clinical and Health Sciences, University of South Australia

  • Director, Drug and Therapeutics Information Service (DATIS), Southern Adelaide Local Health Network

  • President, Council of Pharmacy Schools: Australia and New Zealand

  • Member, National Drug Utilisation Sub-Committee of Pharmaceutical Benefits Advisory Committee (PBAC)

Prof Tim Shaw (since Apr 2020)

  • Professor of Digital Health and Director of Research in Implementation Science and eHealth (RISe), Faculty of Medicine and Health, The University of Sydney, Australia

  • Research Leader, Digital Health Cooperative Research Centre

Prof Allan Wailoo (since Mar 2019)

  • Professor of Health Economics, School of Health & Related Research, The University of Sheffield, United Kingdom

  • Director, National Institute for Health & Care Excellence (NICE) Decision Support Unit

  • Co-Director, National Institute for Health Research (NIHR) Policy Research Unit in Economic Methods of Evaluation in Health and Social Care Interventions

Prof Andrew Wilson (since Mar 2019)

  • Co-Director, Leeder Centre for Health Policy, Economics and Data, School of Public Health, The University of Sydney, Australia

Prof Robyn Ward (since Mar 2017)

  • Executive Dean and Pro Vice-Chancellor, Faculty of Medicine and Health, The University of Sydney, Australia

  • Chair, Commonwealth Pharmaceutical Benefits Advisory Committee (PBAC)

  • Member, Board of the Australian Red Cross Lifeblood

  • Non-Executive Director, Telstra Health

  • Honorary Medical Officer (Oncology), Westmead Hospital, Sydney

Prof Jonathan Craig (from Mar 2017 to Feb 2021 and since May 2024)

  • Vice President & Executive Dean, College of Medicine and Public Health, Flinders University, Australia

  • Chair, Commonwealth Medical Services Advisory Committee (MSAC)

  • Honorary Consultant, Paediatric Nephrology, Women’s and Children’s Hospital Adelaide

Former IAP members

Sarah Fitt
Member from Mar 2021 - Feb 2025

  • Former Chief Executive, Pharmaceutical Management Agency (Pharmac), New Zealand

Meindert Boysen
Member from Mar 2019 - Feb 2023

  • Former Deputy Chief Executive and Director, Centre for Health Technology Evaluation, National Institute for Health and Care Excellence (NICE), United Kingdom

Prof Ron Goeree
Member from Mar 2017 - Feb 2019

  • Professor Emeritus, McMaster University, Canada

Prof Carole Longson
Member from Mar 2017 - Feb 2019

  • Former Director, Centre for Health Technology Evaluation, National Institute for Health and Care Excellence (NICE), United Kingdom

Suzanne McGurn
Member from Mar 2021 - Feb 2023

  • President and Chief Executive Officer, Canadian Agency for Drugs & Technologies in Health (CADTH), Canada

Dr Brian O’Rourke
Member from Mar 2019 - Feb 2021

  • Former President and Chief Executive Officer, Canadian Agency for Drugs & Technologies in Health (CADTH), Canada

Prof Paul Scuffham
Member from Mar 2017 - Feb 2019

  • Director, Centre for Applied Health Economics, Griffith University, Australia

Prof Mark Sculpher
Member from Mar 2017 - Feb 2019

  • Professor, Centre for Health Economics, University of York, United Kingdom

Prof Ken Stein
Member from Mar 2019 - Feb 2021

  • Professor of Public Health, College of Medicine and Health, University of Exeter, United Kingdom

Prof Per Olav Vandvik
Member from Apr 2020 - Feb 2023

  • Chief Executive Officer, MAGIC Evidence Ecosystem Foundation, Norway

ACE Consumer Panel

The ACE Consumer Panel plays an important role in providing strategic advice to ACE and its MOH advisory committees on opportunities to strengthen engagement efforts which meet the needs of patients, carers, and the public and ensure their views are effectively used to inform ACE’s work. The Panel comprises individuals from local patient organisations who represent a broad range of health conditions and have extensive lived experiences engaging with the Singapore healthcare system. Current Panel members have been appointed for a 2-year term from 1 Apr 2024 to 31 Mar 2026.

The Panel’s terms of reference:

  1. Foster effective collaboration between ACE and local patient organisations;

  2. Provide patient and/or societal perspectives to inform ACE’s initiatives to improve health literacy and encourage the appropriate use of health technologies;

  3. Provide guidance on best practices that ACE can use to collect information on patients’ views and experiences;

  4. Champion ACE’s work and encourage meaningful patient involvement in HTAs;

  5. Support ACE to promote greater public understanding of HTA processes and continuously improve how patients and carers are involved in ACE’s work;

  6. Review the format, content, and proposed communication strategies of ACE’s educational resources so that they meet the needs of patients, carers, and the public; and

  7. Provide guidance on opportunities to strengthen engagement with patients and the public across ACE’s different workstreams.

The members of the ACE Consumer Panel and their key appointments in their respective patient organisations are listed below.

ACE Consumer Panel

Adjunct Professor Lau Tang Ching
(Co-Chair)

  • Outgoing Chairperson, The National Arthritis Foundation

Dr Ritu Jain
(Co-Chair)

  • President, Dystrophic Epidermolysis Bullosa Research Association (DEBRA), Singapore & DEBRA International

Dr Kalpana Bhaskaran

  • Advisor, Diabetes Singapore

Ms Magdalene Chia

  • Lead, Caring Hearts Support Group, National University Heart Centre, Singapore

  • Patient Partner, NUHS Family & Patient Partners, NUHS Patient Advocacy & Support Office

Ms Tracy Gan

  • Director, Contact Centre, Service Leadership & Patient Relations and Volunteer Corporate Office, National Healthcare Group Polyclinics

Mr Ellil Mathiyan Lakshmanan

  • Co-Founder & President, Ostomy Association of Singapore

  • Co-Chair, SingHealth Patient Advocacy Network

Ms Melissa Lim

  • President, Brain Tumour Society (Singapore)

  • Patient Advocate, SingHealth Patient Advocacy Network

  • Patient Partner, NUHS Family & Patient Partners

Mr Mark Lin

  • Head of Department, Psychosocial Services, Singapore Cancer Society

Ms Josie Liow

  • Mentor, SingHealth Patient Advocacy Network

Dr Ong Kian Chung

  • Founder & President, Chronic Obstructive Pulmonary Disease Association (Singapore)

Mr Kenneth Mah

  • Vice President, Rare Disorders Society (Singapore)

Ms Peng Hai Ying

  • Chief Executive Officer, Children’s Cancer Foundation

Ms Ai Ling Sim-Devadas

  • Deputy Director, Office of Patient Engagement, NTU Lee Kong Chian School of Medicine

  • Mentor, SingHealth Patient Advocacy Network

  • Member, Global Patient and Family Advisory Board, The Beryl Institute

Ms Sherry Soon

  • Founder, Autoimmune Diseases Singapore

  • Co-Chair, SingHealth Patient Advocacy Network

Dr Rayner Tan

  • Head of Research, The Greenhouse Community Services Ltd

  • Board Member, Project X Society

  • Co-Lead, SG Mental Health Matters

Ms Nidhi Swarup

  • Founding Chair, Alliance of Patients’ Organizations Singapore

  • Founder and President, Crohn’s and Colitis Society of Singapore

Dr Shamala Thilarajah

  • Executive Committee member, Singapore National Stroke Association